Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases
US7932422B2 · kind B2 · utility
3Cited by
0References
5Claims
0Family size
Inventors
Key dates
| Filing date | Oct 3, 2007 |
| Grant date | Apr 26, 2011 |
| Priority date | — |
| Expiry date | Oct 3, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to chlorine Guanabenz derivatives for treating Huntington's disease and other polyglutamine expansion associated diseases. More specifically, it relates to the use of the molecule of formula (I) wherein R═H or Cl and the phenyl group is at least substituted twice, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for treating polyglutamine expansion associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.